However, 2 patients with both BRCA2 and either FANCD2 (Figure 2C) or FANCE (Figure 2D) germline deleterious variants also had complex genomic tumor profiles with numerous copy number gains, losses, and copy-neutral LOH (CN-LOH) events. This evidence concerns the gene FANCE and neoplasm.